Journal of Diabetes and Its Complications
Volume 17, Issue 4 , Pages 205-210 , July 2003

Topical methyl nicotinate-induced skin vasodilation in diabetic neuropathy

  • Antonella Caselli

      Affiliations

    • Joslin-Beth Israel Deaconess Foot Center, Department of Surgery, Microcirculation Laboratory, Beth Israel-Deaconess Medical Center, Harvard Medical School, Boston, MA, USA
    • Department of Internal Medicine, University of Tor Vergata, Rome, Italy
    • Corresponding Author InformationCorresponding author. Microcirculation Laboratory, Palmer 317, West Campus, One Deaconess Road, Boston, MA 02215, USA. Tel.: +1-617-632-7075; fax: +1-617-632-7090
    • ,
  • Tarik Hanane

      Affiliations

    • Joslin-Beth Israel Deaconess Foot Center, Department of Surgery, Microcirculation Laboratory, Beth Israel-Deaconess Medical Center, Harvard Medical School, Boston, MA, USA
    • ,
  • Brady Jane

      Affiliations

    • Joslin-Beth Israel Deaconess Foot Center, Department of Surgery, Microcirculation Laboratory, Beth Israel-Deaconess Medical Center, Harvard Medical School, Boston, MA, USA
    • ,
  • Stephen Carter

      Affiliations

    • Biochemics Inc., Danvers, MA, USA
    • ,
  • Lalita Khaodhiar

      Affiliations

    • Joslin-Beth Israel Deaconess Foot Center, Department of Surgery, Microcirculation Laboratory, Beth Israel-Deaconess Medical Center, Harvard Medical School, Boston, MA, USA
    • ,
  • Aristidis Veves

      Affiliations

    • Joslin-Beth Israel Deaconess Foot Center, Department of Surgery, Microcirculation Laboratory, Beth Israel-Deaconess Medical Center, Harvard Medical School, Boston, MA, USA

Received 9 September 2002 ,Revised 6 November 2002 ,Accepted 13 November 2002.

References 

  1. Abou-Elenin A, Antonios Xydakis A, Hamdy O, Economides PA, Horton ES, Veves A. The effect of aspirin and various iontophoresis solution vehicles in skin microvascular reactivity. Microvascular Research. 2002;63:91–95
  2. American Diabetes Association . Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 1997;20:1183–1197
  3. Arora S, Pomposelli F, LoGerfo FW, Veves A. Cutaneous microcirculation in the neuropathic diabetic foot improves significantly but not completely after successful lower extremity revascularization. Journal of Vascular Surgery. 2002, Mar.;35(3):501–505
  4. Arora S, Smakowski P, Frykberg RG, Simeone LR, Freeman R, LoGerfo FW, et al. Differences in foot and forearm skin microcirculation in diabetic patients with and without neuropathy. Diabetes Care. 1998;21:1339–1344
  5. Boelsma E, Anderson C, Karlsson AM, Ponec M. Microdialysis technique as a method to study the percutaneous penetration of methyl nicotinate through excised human skin, reconstructed epidermis, and human skin in vivo. Pharmaceutical Research. 2000;17:141–147
  6. Caballero AE, Arora S, Saouaf R, Lim SC, Smakowski P, Park JY, et al. Micro- and macro-vascular reactivity is impaired in subjects at risk for type 2 diabetes. Diabetes. 1999;48:1863–1867
  7. Duteil L, Queille C, Poncet M, Ortonne JP, Czernielewski J. Objective assessment of topical corticosteroids and non-steroidal anti-inflammatory drugs in methyl-nicotinate-induced skin inflammation. Clinical and Experimental Dermatology. 1990;15:195–199
  8. Elsner P, Maibach HI. Cutaneous responses to topical methyl nicotinate in human forearm and vulvar skin. Journal of Dermatological Science. 1991;2:341–345
  9. Feldman EL, Stevens MJ, Greene DA. Pathogenesis of diabetic neuropathy. Clinical Neuroscience. 1997;4:365–370
  10. Gean CJ, Tur E, Maibach HI, Guy RH. Cutaneous responses to topical methyl nicotinate in black, oriental, and Caucasian subjects. Archives of Dermatological Research. 1989;281:95–98
  11. Issachar N, Gall Y, Borrel MT, Poelman MC. Correlation between percutaneous penetration of methyl nicotinate and sensitive skin, using laser Doppler imaging. Contact Dermatitis. 1998;39:182–186
  12. Jaap AJ, Shore AC, Tooke JE. Relationship of insulin resistance to microvascular dysfunction in subjects with fasting hyperglycaemia. Diabetologia. 1997;40:238–243
  13. Koivukangas V, Oikarinen A, Salmela PI, Lahti A. Microcirculatory response of skin to benzoic acid and methyl nicotinate in patients with diabetes. Diabetic Medicine. 2000;17:130–133
  14. Lahti A, Vaananen A, Kokkonen EL, Hannuksela M. Acetylsalicylic acid inhibits non-immunologic contact urticaria. Contact Dermatitis. 1987;16:133–135
  15. Mackool BT, Lowitt MH, Dover JS. Skin manifestations of diabetes mellitus. In:  Kahn CR,  Weir GC editor. Joslin's diabetes mellitus. 13th ed.. Philadelphia, PA: Lea and Febiger; 1994;p. 900–911
  16. Mayrovitz HN, Smith J, Delgado M. Variability in skin microvascular vasodilatory responses assessed by laser-Doppler imaging. Ostomy/Wound Management. 1997;43:66–70
  17. Morris SJ, Shore AC, Tooke JE. Responses of the skin microcirculation to acetylcholine and sodium nitroprusside in patients with NIDDM. Diabetologia. 1995;38:1337–1344
  18. Morrow JD, Minton TA, Awad JA, Roberts LJ. Release of markedly increased quantities of prostaglandin D2 from the skin in vivo in humans following the application of sorbic acid. Archives of Dermatology. 1994;130:1408–1412
  19. Pham HT, Exelbert L, Segal-Owens AC, Veves A. A prospective randomized controlled double-blind study of a moisturizer containing 10% urea and 4% lactic acid versus the vehicle for xerosis of the feet in subjects with diabetes. Ostomy/Wound Management. 2002;48:30–36
  20. Roskos KV, Bircher AJ, Maibach HI, Guy RH. Pharmacodynamic measurements of methyl nicotinate percutaneous absorption: the effect of aging on microcirculation. British Journal of Dermatology. 1990;122:165–171
  21. Treffel P, Gabard B. Feasibility of measuring the bioavailability of topical ibuprofen in commercial formulations using drug content in epidermis and a methyl nicotinate skin inflammation assay. Skin Pharmacology. 1993;6:268–275
  22. Tur E, Maibach HI, Guy RH. Percutaneous penetration of methyl nicotinate at three anatomic sites: evidence for an appendageal contribution to transport?. Skin Pharmacology. 1991;4:230–234
  23. Veves A, Akbari CM, Primavera J, Donaghue VM, Zacharoulis D, Chrzan JS, et al. Endothelial dysfunction and the expression of endothelial nitric oxide synthetase in diabetic neuropathy, vascular disease and foot ulceration. Diabetes. 1998;47:457–463
  24. Wahlberg E, Olofsson P, Swedenborg J, Fagrell B. Effects of local hyperemia and edema on the biological zero in laser Doppler fluxmetry (LD). International Journal of Microcirculation, Clinical and Experimental. 1992;11:157–165
  25. Ward JD. Upright posture and the microvasculature in human diabetic neuropathy. A hypothesis. Diabetes. 1997;46(Suppl. 2):S94–S97
  26. Woolfson AD, Malcolm RK, Campbell K, Jones DS, Russell JA. Rheological, mechanical and membrane penetration properties of novel dual drug systems for percutaneous delivery. Journal of Controlled Release. 2000;67:395–408
  27. Young MJ, Boulton AJ, MacLeod AF, Williams DR, Sonksen PH. A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia. 1993;36(2):150–154

PII: S1056-8727(02)00256-8

doi: 10.1016/S1056-8727(02)00256-8

Journal of Diabetes and Its Complications
Volume 17, Issue 4 , Pages 205-210 , July 2003

Article Tools

* Image Usage & Resolution